These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20562606)

  • 21. Late results of the surgical treatment of 125 patients with short-segment Barrett esophagus.
    Csendes A; Braghetto I; Burdiles P; Smok G; Henríquez A; Burgos AM
    Arch Surg; 2009 Oct; 144(10):921-7. PubMed ID: 19841359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-year subjective, objective, quality of life, and endoscopic follow-up after laparoscopic Nissen-Rossetti in patients with columnar-lined esophagus.
    Marano S; Mattacchione S; Luongo B; Mingarelli V; Campagna G; Tosato F
    Surg Laparosc Endosc Percutan Tech; 2013 Jun; 23(3):292-8. PubMed ID: 23751995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barrett's esophagus: the role of laparoscopic fundoplication.
    Abbas AE; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Miller DL; Pairolero PC
    Ann Thorac Surg; 2004 Feb; 77(2):393-6. PubMed ID: 14759403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial regression of childhood Barrett's esophagus after fundoplication.
    Hassall E; Weinstein WM
    Am J Gastroenterol; 1992 Oct; 87(10):1506-12. PubMed ID: 1415114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery.
    McCarthy M; Wilkinson ML
    Gastrointest Endosc; 1999 Jan; 49(1):129-30. PubMed ID: 10048955
    [No Abstract]   [Full Text] [Related]  

  • 26. [Laparoscopic Nissen fundoplication and esophageal intestinal metaplasia: preliminary observations].
    Fiorentino E; Cabibi D; Pantuso G; Latteri F; Mastrosimone A; Valenti A
    Chir Ital; 2005; 57(1):53-8. PubMed ID: 15832738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features.
    Gurski RR; Peters JH; Hagen JA; DeMeester SR; Bremner CG; Chandrasoma PT; DeMeester TR
    J Am Coll Surg; 2003 May; 196(5):706-12; discussion 712-3. PubMed ID: 12742201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biopsy and endoscopic prospective study of the prevalence of intestinal metaplasia in the gastroesophageal junction in controls and in patients with gastroesophageal reflux].
    Csendes A; Smok G; Sagastume H; Rojas J
    Rev Med Chil; 1998 Feb; 126(2):155-61. PubMed ID: 9659750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Squamous mucosa overlying columnar epithelium in Barrett's esophagus in the absence of anti-reflux surgery.
    Sampliner RE; Steinbronn K; Garewal HS; Riddell RH
    Am J Gastroenterol; 1988 May; 83(5):510-2. PubMed ID: 3364411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proliferative activity in Barrett's esophagus before and after antireflux surgery.
    Chen LQ; Hu CY; Gaboury L; Pera M; Ferraro P; Duranceau AC
    Ann Surg; 2001 Aug; 234(2):172-80. PubMed ID: 11505062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of fundoplication on proliferative and anti-apoptotic activity of esophageal mucosa in gastroesophageal reflux disease: 4-year follow-up study.
    Rantanen T; Oksala N; Honkanen T; Räsänen J; Sihvo E; Mattila J; Paimela H; Paavonen T; Salo J
    J Dig Dis; 2011 Aug; 12(4):263-71. PubMed ID: 21791020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
    Triadafilopoulos G; Kaczynska M; Iwane M
    Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
    Corey KE; Schmitz SM; Shaheen NJ
    Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association between symptomatic gastroesophageal reflux and Barrett's esophagus].
    Trujillo-Benavides OE; Baltazar-Montúfar P; Angeles-Garay U; Ramírez-Mendoza P; Navarro-García AM; Paredes-Cruz E; Méndez del Monte R; Guerrero-Hernández M
    Rev Gastroenterol Mex; 2005; 70(1):14-9. PubMed ID: 16170957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Barrett esophagus and Barrett carcinoma].
    Kruyt PH; van Sandick JW; van Lanschot JJ; Offerhaus GJ; Tytgat GN; Obertop H
    Ned Tijdschr Geneeskd; 1997 May; 141(18):869-73. PubMed ID: 9273450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical management of Barrett's esophagus.
    Clark GW; DeMeester TR
    Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of intestinal metaplasia in patients with and without peptic strictures.
    Kim SL; Wo JM; Hunter JG; Davis LP; Waring JP
    Am J Gastroenterol; 1998 Jan; 93(1):53-5. PubMed ID: 9448174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A New Pathologic Assessment of Gastroesophageal Reflux Disease: The Squamo-Oxyntic Gap.
    Chandrasoma P; DeMeester T
    Adv Exp Med Biol; 2016; 908():41-78. PubMed ID: 27573767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.